On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
June 15, 2018
Changes to a mandatory Continuing Education requirement for pharmacists during the current biennium ending on September 30, 2019 Continue reading
June 8, 2018
The Quarterly Performance Report for the third quarter of the 2017-2018 fiscal year is now available online. Continue reading